arrow_back Trending Legislation
Share share

Tardive Dyskinesia Awareness Week Designated to Highlight Medication Side Effects.

The Senate designated the first week of May 2023 as Tardive Dyskinesia Awareness Week to highlight this serious movement disorder affecting over 600,000 Americans. TD is often a side effect of long-term use of certain medications for mental health or gastrointestinal issues. The resolution aims to encourage better public understanding and improved screening practices by healthcare providers.
Key points
Official designation of an awareness week to increase public and medical community knowledge about Tardive Dyskinesia (TD).
TD is an involuntary movement disorder linked to common medications used for serious mental illnesses and stomach disorders.
The resolution encourages citizens to become better informed about TD risks and symptoms, potentially leading to earlier diagnosis.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
A resolution designating the week of May 1, 2023, through May 7, 2023, as "Tardive Dyskinesia Awareness Week".
Print number: SRES 197
Sponsor: Sen. Mullin, Markwayne [R-OK]
Process start date: 2023-05-04
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Tardive Dyskinesia Awareness Week Designated to Highlight Medication Side Effects.

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is SRES 197.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2023-05-04.

What are the main provisions?

Key points include:

  • Official designation of an awareness week to increase public and medical community knowledge about Tardive Dyskinesia (TD).
  • TD is an involuntary movement disorder linked to common medications used for serious mental illnesses and stomach disorders.
  • The resolution encourages citizens to become better informed about TD risks and symptoms, potentially leading to earlier diagnosis.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Mullin, Markwayne [R-OK].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

Analysis and Potential Impact of SRES 197

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health